A risk-benefit analysis of French high fish consumption: A QALY approach

被引:32
|
作者
Guevel, Marie-Renee [1 ]
Sirot, Veronique [1 ]
Volatier, Jean-Luc
Leblanc, Jean-Charles [1 ]
机构
[1] French Food Safety Agcy, F-94701 Maisons Alfort, France
关键词
fish consumption; methylmercury; n-3; PUFAs; QALY; risk-benefit;
D O I
10.1111/j.1539-6924.2008.01001.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The health risk and the nutritional benefit of a food are usually assessed separately. Toxicologists recommend limiting the consumption of certain fish because of methylmercury; while nutritionists recommend eating more oily fish because of omega 3. A common evaluation is imperative to provide coherent recommendations. In order to evaluate the risks along with the benefits related to fish consumption, a common metric based on the quality-adjusted life year (QALY) method has been used. The impact of a theoretical change from a medium n-3 PUFAs intake to a high intake is studied, in terms of the cardiovascular system (CHD mortality, stroke mortality and morbidity) and on fetal neuronal development (IQ loss or gain). This application can be considered as a sensitive analysis of the model used and looks at the impact of changing the dose-response relationships between cardiovascular diseases and n-3 PUFAs intakes. Results show that increasing fish consumption may have a beneficial impact on health. However, the confidence interval of the overall estimation has a negative lower bound, which means that this increase in fish consumption may have a negative impact due to MeHg contamination. Some limits of the QALY approach are identified. The first concerns determination of the dose-response relationships. The second concerns the economic origins of the approach and of individual preferences. Finally, since only one beneficial aspect and one risk element were studied, consideration should be given to how other beneficial and risk components may be integrated in the model.
引用
收藏
页码:37 / 48
页数:12
相关论文
共 50 条
  • [41] BRAFO -: Risk-benefit analysis of foods
    Boobis, Alan
    Contor, Laura
    Kind, Paul
    Mueller, Detlef
    Rechkemmer, Gerhard
    Verhagen, Hans
    Szoradi, Andras
    ANNALS OF NUTRITION AND METABOLISM, 2007, 51 : 393 - 394
  • [42] Labour analgesia - A risk-benefit analysis
    Eberle, RL
    Norris, MC
    DRUG SAFETY, 1996, 14 (04) : 239 - 251
  • [43] ADVICE AND CONSENT + RISK-BENEFIT ANALYSIS
    BONINE, JE
    ATLANTIC, 1979, 243 (05): : 31 - 31
  • [44] Basic aspects of risk-benefit analysis
    Beckmann, J
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1999, 25 (01): : 89 - 95
  • [45] Quantitative risk-benefit analysis of natalizumab
    Thompson, J. P.
    Noyes, K.
    Dorsey, E. R.
    Schwid, S. R.
    Holloway, R. G.
    NEUROLOGY, 2008, 71 (05) : 357 - 364
  • [46] Hormones and cancer: Risk-benefit analysis
    Sevelda, P
    Salzer, H
    GYNAKOLOGISCH-GEBURTSHILFLICHE RUNDSCHAU, 1998, 38 (02): : 61 - 63
  • [47] QUANTITATIVE RISK-BENEFIT ANALYSIS OF NATALIZUMAB
    Steiner, Israel
    NEUROLOGY, 2009, 72 (20) : 1791 - 1791
  • [48] A TIERED APPROACH FOR RISK-BENEFIT ASSESSMENT OF FOODS
    Fransen, Heidi
    de Jong, Nynke
    Hendriksen, Marieke
    Mengelers, Marcel
    Castenmiller, Jacqueline
    Hoekstra, Jeljer
    van Leeuwen, Rolaf
    Verhagen, Hans
    ANNALS OF NUTRITION AND METABOLISM, 2009, 55 : 661 - 661
  • [49] A Tiered Approach for Risk-Benefit Assessment of Foods
    Fransen, Heidi
    de Jong, Nynke
    Hendriksen, Marieke
    Mengelers, Marcel
    Castenmiller, Jacqueline
    Hoekstra, Jeljer
    van Leeuwen, Rolaf
    Verhagen, Hans
    RISK ANALYSIS, 2010, 30 (05) : 808 - 816
  • [50] A RISK-BENEFIT ANALYSIS FOR THE TREATMENT OF HYPERTENSION
    BULPITT, CJ
    POSTGRADUATE MEDICAL JOURNAL, 1993, 69 (816) : 764 - 774